| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.00086 | 1 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.0009 | 1 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.00079 | 1 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.00085 | 1 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.00056 | 1 |